Although multiple studies have identified pro-inflammatory effects of PCSK9 in promoting atherosclerosis, several studies have found that hs-CRP levels were not decreased despite the anti-inflammatory changes after treatment with PCSK9 inhibitors [62, 63]. Here, PCSK9 is linked to atherosclerosis.